Kerlinsky Biotech Inc is categorized under Biological Research in Albuquerque, NM and active since 2007.
Kerlinsky Biotech Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Dr Daniel Kerlinsky at the company’s single location by writing to 7007 Wyoming Boulevard Ne E3, Albuquerque, New Mexico NM 87109 or by phoning (505) 884-0112. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kerlinsky Biotech Inc |
| Contact Person: | Dr Daniel Kerlinsky |
| Address: | 7007 Wyoming Boulevard Ne E3, Albuquerque, New Mexico 87109 |
| Phone Number: | (505) 884-0112 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Kerlinsky Biotech Inc was started in 2007 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dr Daniel Kerlinsky for inquiries that concern Kerlinsky Biotech Inc by calling the company number (505) 884-0112, as your correspondence is most welcome. Additionally, the physical location of the single location of Kerlinsky Biotech Inc can be found at the coordinates 35.158723,-106.560187 as well as the street address 7007 Wyoming Boulevard Ne E3 in Albuquerque, New Mexico 87109.
For its online presence, you may visit Kerlinsky Biotech Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.